[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of the Company by offering opportunities to directors, officers, employees and eligible consultants of the Company to acquire and maintain stock ownership in the Company]
[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of the Company by offering opportunities to directors, officers, employees and eligible consultants of the Company to acquire and maintain stock ownership in the Company]
[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS;MPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of thempany by offering opportunities to directors, officers, employees and eligiblensultants of thempany to acquire and maintain stock ownership in thempany]
[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS;MPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of thempany by offering opportunities to directors, officers, employees and eligiblensultants of thempany to acquire and maintain stock ownership in thempany]
[SCHEDULE 14C INFORMATION X] [ Preliminary Information Statement [] [ ] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]
[SCHEDULE 14C INFORMATION X] [ Preliminary Information Statement [] [ ] Definitive Information Statement CHINA PHARMA H OLDINGS, . Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]
[CHINA PHARMA HOLDINGS, INC. CHARTER OF THE NOMINATING AND COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I. Purpose The Nominating and Compensation Committee (the “Committee”) of the Board of Directors of China Pharma Holdings, Inc. (the “Company”) is established to: • Formulate goals and objectives relating to compensation payable to the]
[CHINA PHARMA HOLDINGS, INC. CHARTER OF THE NOMINATING AND COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I. Purpose The Nominating and Compensation Committee (the “Committee”) of the Board of Directors of China Pharma Holdings, Inc. (the “Company”) is established to: • Formulate goals and objectives relating to compensation payable to the]
